News2 years ago
Roche Sceptical about Investing More in ‘Guided-Missile’ ADC Cancer Drugs
Roche remains sceptical about investing more in antibody-drug conjugates (ADCs), which have been described as “guided-missile” cancer drugs, even as they attract heightened attention in the...